Financing immunizations in the United States

Area of Science:

• Public Health
• Health Policy
• Immunization Financing

Background:

• Childhood immunizations in the U.S. are funded through public and private sectors.
• Federal support began in 1963 with the Vaccination Assistance Act (Section 317) and expanded with the Vaccines for Children (VFC) program in 1994.
• Adult immunization historically lacked federal support until Medicare coverage for pneumococcal and influenza vaccines was introduced in 1981 and 1993, respectively.

Purpose of the Study:

• To summarize the historical evolution of immunization financing in the United States.
• To identify current challenges within the existing immunization funding system.
• To discuss potential solutions for improving vaccine accessibility and affordability.

Main Methods:

• Historical review of federal immunization support legislation and programs.
• Analysis of vaccine purchasing data by funding source (VFC, Section 317, state/local, private).
• Discussion of the impact of new, high-cost vaccines on the current financing model.

Main Results:

• In 2002, the private sector funded 43% of childhood vaccines, while VFC funded 41%.
• Section 317 and state/local governments funded 11% and 5%, respectively.
• The introduction of expensive vaccines like pneumococcal conjugate vaccine has exposed limitations in the current financing structure.

Conclusions:

• The U.S. immunization financing system faces challenges, particularly with the rising cost of newer vaccines.
• Addressing these weaknesses is crucial for maintaining high vaccination rates in both children and adults.
• Policy adjustments are needed to ensure sustainable and equitable access to all recommended immunizations.